发明名称 ORAL DRUG COMPLIANCE MONITORING USING RADIO FREQUENCY IDENTIFICATION TAGS
摘要 <p num="1"><br/><br/><br/>A device useful for oral drug delivery device consisting of: (a) a capsule, <br/>tablet or pill designed to disperse in the gastrointestinal system; (b) an <br/>RFID tag positioned in the capsule, tablet or pill, the RFID tag comprising an <br/>antenna; (c) an object selected from the group consisting of a magnet, a <br/>ferromagnetic object, a ferrite object and an electromagnetic shielding object <br/>positioned within, over or adjacent the antenna of the RFID tag to alter the <br/>antenna characteristics of the RFID tag so that if the RFID tag is <br/>interrogated before the capsule, tablet or pill disperses in the <br/>gastrointestinal system, the response of the RFID tag is sufficiently altered <br/>or attenuated to determine that the capsule, tablet or pill has not dispersed <br/>in the gastrointestinal system and so that if the RFID tag is interrogated <br/>after the capsule, tablet or pill has dispersed in the gastrointestinal <br/>system, the object separates from the RFID tag so that the response of the <br/>RFID tag is sufficiently detectable to determine that the capsule, tablet or <br/>pill has dispersed in the gastrointestinal system. Alternatively, a switch can <br/>be used to signal ingestion of the device, and change the response of the <br/>device. In another embodiment, the instant invention is a device useful for <br/>oral drug delivery, consisting of: (a) a capsule, tablet or pill designed to <br/>disperse in the gastrointestinal system; (b) a first non-anti-collision RFID <br/>tag positioned in the capsule; (c) a second non-anti-collision RFID tag <br/>positioned in the capsule, so that if the RFID tags are interrogated by an <br/>RFID reader before the capsule, tablet or pill disperses in the <br/>gastrointestinal system, the response of the RFID tags collide and so that <br/>after the dispersible material of the capsule has dispersed in the <br/>gastrointestinal system thereby allowing the first and second non-anti-<br/>collision tags to separate from each other, then the response of the RFID tags <br/>is sufficiently different from each other to determine that the capsule has <br/>dispersed in the gastrointestinal system.<br/>
申请公布号 CA2609007(A1) 申请公布日期 2006.11.30
申请号 CA20062609007 申请日期 2006.05.18
申请人 DOW GLOBAL TECHNOLOGIES, INC. 发明人 STRAND, DEIDRE A.;SIMON, JAIME;BERNIUS, MARK T.;WARREN, MALCOLM W.;JONES, CHRISTOPHER M.;BABINEC, SUSAN J.;MERCURE, PETER KIP;ROSNER, BETTINA M.;CRANLEY, PAUL E.;CASTILLO, FLOR A.;HALEY, ROBERT PAUL;WHITE, DOUGLAS P.;MCDOUGALL, CHRIS W.;KALANTAR, THOMAS H.;FLETCHER, ROBERT B.;PRESSLER, MICHELLE A.;FELIX, MARK S. B.;DANOWSKI, KRISTINE L.;SUN, LARRY
分类号 A61K9/48;A61K9/20;G06K19/077 主分类号 A61K9/48
代理机构 代理人
主权项
地址